Keith Ahamad

1.4k total citations · 1 hit paper
41 papers, 932 citations indexed

About

Keith Ahamad is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Infectious Diseases. According to data from OpenAlex, Keith Ahamad has authored 41 papers receiving a total of 932 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Epidemiology, 30 papers in Public Health, Environmental and Occupational Health and 10 papers in Infectious Diseases. Recurrent topics in Keith Ahamad's work include Opioid Use Disorder Treatment (29 papers), Substance Abuse Treatment and Outcomes (18 papers) and HIV, Drug Use, Sexual Risk (17 papers). Keith Ahamad is often cited by papers focused on Opioid Use Disorder Treatment (29 papers), Substance Abuse Treatment and Outcomes (18 papers) and HIV, Drug Use, Sexual Risk (17 papers). Keith Ahamad collaborates with scholars based in Canada, United States and Ireland. Keith Ahamad's co-authors include Evan Wood, Julie Bruneau, T. Cameron Wild, Benedikt Fischer, Marie-Ève Goyer, Peter Selby, Seonaid Nolan, Ján Klimas, Thomas Kerr and Nadia Fairbairn and has published in prestigious journals such as JAMA, American Journal of Psychiatry and Clinical Pharmacology & Therapeutics.

In The Last Decade

Keith Ahamad

39 papers receiving 910 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Management of opioid use disorders: a national clinical practice guideline

2018 297 citations Julie Bruneau, Keith Ahamad et al. Canadian Medical Association Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Keith Ahamad Canada	15	659	508	175	167	124	41	932
Seonaid Nolan Canada	19	823 1.2×	720 1.4×	201 1.1×	185 1.1×	167 1.3×	67	1.3k
Ján Klimas Ireland	19	736 1.1×	649 1.3×	176 1.0×	149 0.9×	255 2.1×	85	1.2k
Michael Landen United States	17	553 0.8×	449 0.9×	155 0.9×	167 1.0×	205 1.7×	40	1.1k
Zoe Weinstein United States	17	833 1.3×	741 1.5×	198 1.1×	100 0.6×	150 1.2×	48	1.0k
Darius A. Rastegar United States	18	365 0.6×	348 0.7×	100 0.6×	69 0.4×	99 0.8×	47	851
Katharina Wiest United States	12	833 1.3×	683 1.3×	275 1.6×	154 0.9×	75 0.6×	21	1.1k
Alex S. Bennett United States	19	773 1.2×	586 1.2×	192 1.1×	149 0.9×	123 1.0×	62	1.0k
Soraya Mayet United Kingdom	15	657 1.0×	564 1.1×	217 1.2×	71 0.4×	119 1.0×	25	984
Nick Lintzeris Australia	17	769 1.2×	693 1.4×	187 1.1×	138 0.8×	107 0.9×	27	1.2k
Amy Gibson Australia	16	586 0.9×	582 1.1×	224 1.3×	58 0.3×	99 0.8×	30	871

Countries citing papers authored by Keith Ahamad

Since Specialization

Citations

This map shows the geographic impact of Keith Ahamad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith Ahamad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith Ahamad more than expected).

Fields of papers citing papers by Keith Ahamad

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith Ahamad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith Ahamad. The network helps show where Keith Ahamad may publish in the future.

Co-authorship network of co-authors of Keith Ahamad

This figure shows the co-authorship network connecting the top 25 collaborators of Keith Ahamad. A scholar is included among the top collaborators of Keith Ahamad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith Ahamad. Keith Ahamad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Socías, M. Eugenia, et al.. (2024). Associations of Methadone and BUP/NX Dose Titration Patterns With Retention in Treatment and Opioid Use in Individuals With Prescription-Type Opioid Use Disorder: Secondary Analysis of the OPTIMA Study. Journal of Addiction Medicine. 18(2). 167–173. 2 indexed citations

Tatar, Ovidiu, et al.. (2023). Associations of methadone and buprenorphine‐naloxone doses with unregulated opioid use, treatment retention, and adverse events in prescription‐type opioid use disorders: Exploratory analyses of the OPTIMA study. American Journal on Addictions. 32(5). 469–478. 12 indexed citations

Chenoweth, Meghan J., Didier Jutras‐Aswad, Keith Ahamad, et al.. (2023). Pharmacogenetics of Biochemically Verified Abstinence in an Opioid Agonist Therapy Randomized Clinical Trial of Methadone and Buprenorphine/Naloxone. Clinical Pharmacology & Therapeutics. 115(3). 506–514.

Scheuermeyer, Frank, Daniel Lane, Keith Ahamad, et al.. (2023). Patient opinion and acceptance of emergency department buprenorphine/naloxone to-go home initiation packs. Canadian Journal of Emergency Medicine. 25(10). 802–807. 2 indexed citations

Jutras‐Aswad, Didier, Bernard Le Foll, Keith Ahamad, et al.. (2022). Flexible Buprenorphine/Naloxone Model of Care for Reducing Opioid Use in Individuals With Prescription-Type Opioid Use Disorder: An Open-Label, Pragmatic, Noninferiority Randomized Controlled Trial. American Journal of Psychiatry. 179(10). 726–739. 33 indexed citations

Ahamad, Keith, et al.. (2021). Anticraving medication for moderate to severe alcohol use disorder. Canadian Medical Association Journal. 193(19). E695–E695. 1 indexed citations

Ti, Lianping, Nadia Fairbairn, Keith Ahamad, et al.. (2020). Building a hospital‐based addiction medicine consultation service in Vancouver, Canada: the path taken and lessons learned. Addiction. 116(7). 1892–1900. 18 indexed citations

Ahamad, Keith, et al.. (2019). Factors associated with willingness to wear an electronic overdose detection device. Addiction Science & Clinical Practice. 14(1). 23–23. 15 indexed citations

Leece, Pamela, Kimberly Corace, Carol Strıke, et al.. (2019). Barriers and facilitators to buprenorphine use for opioid agonist treatment: protocol for a scoping review. BMJ Open. 9(12). e032285–e032285. 6 indexed citations

10.

Scheuermeyer, Frank, Eric Grafstein, Jane A. Buxton, et al.. (2018). Safety of a Modified Community Trailer to Manage Patients with Presumed Fentanyl Overdose. Journal of Urban Health. 96(1). 21–26. 6 indexed citations

11.

Reddon, Hudson, Kora DeBeck, M‐J Milloy, et al.. (2017). Increasing diversion of methadone in Vancouver, Canada, 2005–2015. Journal of Substance Abuse Treatment. 85. 10–16. 7 indexed citations

12.

Panagiotoglou, Dimitra, Emanuel Krebs, Jeong Eun Min, et al.. (2017). Initiating HCV treatment with direct acting agents in opioid agonist treatment: When to start for people co-infected with HIV?. International Journal of Drug Policy. 47. 169–176. 5 indexed citations

13.

Klimas, Ján, Ryan McNeil, Keith Ahamad, et al.. (2017). Two birds with one stone: experiences of combining clinical and research training in addiction medicine. BMC Medical Education. 17(1). 22–22. 15 indexed citations

14.

Klimas, Ján, Will Small, Keith Ahamad, et al.. (2017). Barriers and facilitators to implementing addiction medicine fellowships: a qualitative study with fellows, medical students, residents and preceptors. Addiction Science & Clinical Practice. 12(1). 21–21. 10 indexed citations

15.

Ahamad, Keith, et al.. (2016). A Needs Assessment of the Number of Comprehensive Addiction Care Physicians Required in a Canadian Setting. Journal of Addiction Medicine. 10(4). 255–261. 11 indexed citations

16.

Dong, Huiru, Keith Ahamad, Kanna Hayashi, et al.. (2015). Impact of binge alcohol on mortality among people who inject drugs. Addictive Behaviors Reports. 2. 28–32. 14 indexed citations

17.

Nosyk, Bohdan, Emanuel Krebs, Jeong Eun Min, et al.. (2015). The ‘Expanded HIV care in opioid substitution treatment’ (EHOST) cluster-randomized, stepped-wedge trial: A study protocol. Contemporary Clinical Trials. 45(Pt B). 201–209. 5 indexed citations

18.

Ahamad, Keith, Kanna Hayashi, Paul Nguyen, et al.. (2015). Effect of low-threshold methadone maintenance therapy for people who inject drugs on HIV incidence in Vancouver, BC, Canada: an observational cohort study. The Lancet HIV. 2(10). e445–e450. 40 indexed citations

19.

Ahamad, Keith, M‐J Milloy, Paul Nguyen, et al.. (2015). Factors associated with willingness to take extended release naltrexone among injection drug users. Addiction Science & Clinical Practice. 10(1). 12–12. 26 indexed citations

20.

Ahamad, Keith, et al.. (2014). Gender influences on initiation of injecting drug use. The American Journal of Drug and Alcohol Abuse. 40(2). 151–156. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact